Altimmune, Inc. (ALT)

Altimmune Revenue

In the year 2023, Altimmune had annual revenue of $426.00K, a decrease of -726.47%. Revenue in the quarter ending December 31, 2023 was $37.00K, a -133.64% decrease year-over-year.

• Revenue (ttm): $426.00K
• Revenue Growth: -726.47%
• P/S Ratio: 1,176.60
• Revenue / Employee: $7,220
• Employees: 59
• Market Cap: 501.23M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	426.00K	494.00K	-726.47%
Dec 31, 2022	-68.00K	-4.48M	-101.54%
Dec 31, 2021	4.41M	-3.78M	-46.12%
Dec 31, 2020	8.19M	2.38M	41.09%
Dec 31, 2019	5.80M	-4.53M	-43.85%
Dec 31, 2018	10.33M	-407.15K	-3.79%
Dec 31, 2017	10.74M	7.50M	231.82%
Dec 31, 2016	3.24M	-7.40M	-69.59%
Dec 31, 2015	10.64M	450.46K	4.42%
Dec 31, 2014	10.19M	-7.72M	-43.11%
Dec 31, 2013	17.91M	-7.26M	-28.85%
Dec 31, 2012	25.18M	909.61K	3.75%
Dec 31, 2011	24.27M	3.27M	15.59%
Dec 31, 2010	20.99M	-6.56M	-23.80%
Dec 31, 2009	27.55M	-5.36M	-16.29%
Dec 31, 2008	32.91M	18.27M	124.75%
Dec 31, 2007	14.64M	12.98M	780.39%
Dec 31, 2006	1.66M	1.08M	183.80%
Dec 31, 2005	586.07K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.